LBBW Aktienanleihe OMV 25.10.2024/ DE000LB4L9B1 /
2024-09-10 9:52:11 AM | Chg.-0.110 | Bid10:10:41 AM | Ask10:10:41 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
99.200EUR | -0.11% | 99.180 Bid Size: 250,000 |
99.380 Ask Size: 250,000 |
OMV AG | 36.11 EUR | 2024-10-25 | Call |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center